Abstract. Bromocriptine is widely used in the treatment of hyperprolactinaemia. It has also been shown to be effective in reducing the size of large pituitary tumours, particularly those secreting prolactin. We describe CSF rhinorrhoea in two such patients during treatment with bromocriptine and believe that this complication developed as a result of contraction of the tumour exposing a defect in the sella floor. The possibility of this complication, especially in patients with downward extension of tumour, should be noted.
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Cerebrospinal fluid (CSF) rhinorrhoea is a rare but well documented complication of pituitary tumours (Cole & Keene 1980) . It has also been described during bromocriptine treatment of pa¬ tients after incomplete resection of prolactinomas (Aronoff et al. 1979; Baskin & Wilson 1982) and after radiotherapy (Landolt 1982 (Thorner et al. 1980 ). We believe that the development of CSF rhinorrhoea in the two patients described here was a result of contraction of the tumour by bromocriptine ex¬ posing a defect in the sella floor. This is supported by the findings at surgery and the fact that the hormone levels in the second patient fell substan¬ tially during the first 6 weeks of treatment. The initial hormone levels in the first patient were not accurately known and therefore a fall could not be confirmed.
CSF leakage recurred in both these patients after the first operation. In the first case it recurred within days and was unrelated to the use of bromo¬ criptine. In the second case bromocriptine had been restarted and may have resulted in contrac¬ tion of residual tumour and exposure of the surgi¬ cal defect in the sella floor. That was the suggested reason for CSF leakage in the three cases where it was described following incomplete resection of prolactinomas (Aronoff et al. 1979; Baskin & Wil¬ son 1982) . Rapid tumour shrinkage caused by irradiation combined with bromocriptine therapy was also considered to be a factor in the develop¬ ment of CSF rhinorrhoea in three patients repor¬ ted by Landolt (1982) , two of whom had prior surgery and the third had very extensive tumour invasion of the clivus and air sinuses.
The surgical treatment of CSF rhinorrhoea in the presence of invasive pituitary tumours is dif¬ ficult as it is unlikely that all tumour tissue can be removed (Guiot 1978) . Previous investigators (Cole & Keene 1980) 
